Anti-Fibrotic Effects of Astragaloside IV in Systemic Sclerosis

Publisher： Karger

E-ISSN： 1421-9778|34|6|2105-2116

ISSN： 1015-8987

Source： Cellular Physiology and Biochemistry, Vol.34, Iss.6, 2014-11, pp. : 2105-2116

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Anti-fibrotic Effects via Regulation of Transcription Factor Sp1 on Hepatic Stellate Cells

By  

Cellular Physiology and Biochemistry, Vol. 29, Iss. 1-2, 2012-03 ,pp. : 51-60

Karger

Access to resources Recommend Favorite

Anti-Fibrotic Effect of Plumbagin on CCl4-Lesioned Rats

By  

Cellular Physiology and Biochemistry, Vol. 35, Iss. 4, 2015-03 ,pp. : 1599-1608

Karger

Access to resources Recommend Favorite

MicroRNA-328, a Potential Anti-Fibrotic Target in Cardiac Interstitial Fibrosis

By  

Cellular Physiology and Biochemistry, Vol. 39, Iss. 3, 2016-08 ,pp. : 827-836

Karger

Access to resources Recommend Favorite

Effects of Astragaloside IV Against the TGF-β1-Induced Epithelial-to-Mesenchymal Transition in Peritoneal Mesothelial Cells by Promoting Smad 7 Expression

By  

Cellular Physiology and Biochemistry, Vol. 37, Iss. 1, 2015-08 ,pp. : 43-54

Karger

Access to resources Recommend Favorite

Advances in Skin Substitutes—Potential of Tissue Engineered Skin for Facilitating Anti-Fibrotic Healing

By Varkey Mathew   Ding Jie   Tredget Edward E.  

Journal of Functional Biomaterials, Vol. 6, Iss. 3, 2015-07 ,pp. : 547-563

MDPI

Access to resources Recommend Favorite